Skip to main content
Home
FULL MENU Close Menu
Home
Home

Natasha Antonovich, PharmD, BCPS

Article

Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS:Review of the Evidence

Author:
Natasha Antonovich, PharmD, BCPS

Background: There are currently no disease-modifying therapies (DMTs) on the market approved for nonactive secondary...

  • Read More

Article

Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System

Author:
Kathryn Tortorice, PharmD, BCPS
Natasha Antonovich, PharmD, BCPS

Disease modifying therapies that offer advantages for patients with multiple sclerosis are entering clinical trials and are rapidly being approved...

  • Read More

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close